-+ 0.00%
-+ 0.00%
-+ 0.00%

Arrowhead Pharmaceuticals Launches Phase 1/2a Trial of ARO-MAPT for Alzheimer’s Disease

路透·12/08/2025 12:30:33

登录查看新闻详情